Press release
Hereditary Angioedema Therapeutic Market to reach USD 14.19 Bn by 2029, emerging at a CAGR of 16.79 percent and forecast 2023-2029
Hereditary Angioedema Therapeutic Market
The driving force behind the Hereditary Angioedema Therapeutic market's growth is the increasing global prevalence of hereditary angioedema (HAE). According to the National Organization for Rare Disorders (NORD), approximately 1-9 people per 100,000 population are affected by HAE, though the actual number may be significantly higher due to under-reporting and misdiagnosis. Maximize Market Research's report also analyzes the revenue impact of the COVID-19 pandemic on market leaders, followers, and disruptors.
To compile this comprehensive report, Maximize Market Research employed a rigorous research methodology. The study provides valuable insights into the market's current status, forecasts its size and trends, and presents complex data in an easily understandable manner.
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/37140
Hereditary Angioedema Therapeutic Market Dynamics:
The primary driver behind the growth of the Hereditary Angioedema Therapeutic Market is the rising global incidence of hereditary angioedema (HAE). According to the National Organization for Rare Disorders (NORD), approximately 1-9 people per 100,000 population are affected by HAE. However, this number is likely significantly higher due to under-reporting and misdiagnosis.
Lack of awareness about HAE is a major obstacle, leading to misdiagnosis and inadequate treatment for patients. International organizations like HAE International play a crucial role in addressing this challenge.
Hereditary Angioedema Therapeutic Market Regional Insights:
Geographically, the Hereditary Angioedema market is segmented into APAC, North America, Europe, MEA & Africa, and Latin America. North America led in terms of revenue in 2022 due to new product launches by major players, better reimbursement scenarios, and a well-developed healthcare infrastructure. Growing patient awareness levels and the introduction of novel therapies for hereditary angioedema management are expected to drive the market in this region.
Request For Free Inquiry Report:https://www.maximizemarketresearch.com/inquiry-before-buying/37140
Hereditary Angioedema Therapeutic Market Segmentation:
by Drug Class
C1-esterase inhibitor
Bradykinin B2 receptor antagonist
Kallikrein inhibitor
Others
by Treatment Type
Prophylaxis
On-demand
by Route of Administration
Intravenous
Subcutaneous
Oral
Hereditary Angioedema Therapeutic Market Key Players:
1.BioCryst Pharmaceuticals, Inc.
2.Ionis Pharmaceuticals, Inc.
3.Pharming Group N.V.
4.CSL Limited
5.Shire Plc
6.Attune Pharmaceuticals, Inc.
7.Adverum Biotechnologies, Inc.
8.KalVista Pharmaceuticals, Inc.
9.Novartis AG
10.CENTOGENE AG
11.Sanofi
12.Takeda Pharmaceutical Company Limited
13.Cipla
Get to Know More About This Market Study:https://www.maximizemarketresearch.com/market-report/hereditary-angioedema-therapeutic-market/37140/
Table of content for the Hereditary Angioedema Therapeutic Market includes:
1. Global Hereditary Angioedema Therapeutic Market: Research Methodology
2. Global Hereditary Angioedema Therapeutic Market: Executive Summary
• Market Overview and Definitions
• Introduction to the Global Market
• Summary
• Key Findings
• Recommendations for Investors
• Recommendations for Market Leaders
• Recommendations for New Market Entry
3.Global Hereditary Angioedema Therapeutic Market: Competitive Analysis
• MMR Competition Matrix
• Market Structure by region
• Competitive Benchmarking of Key Players
• Consolidation in the Market
• M&A by region
• Key Developments by Companies
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Market Dynamics
• PORTERS Five Forces Analysis
• PESTLE
• Regulatory Landscape by region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America
• COVID-19 Impact
4 . Company Profile: Key players
• Company Overview
• Financial Overview
• Global Presence
• Capacity Portfolio
• Business Strategy
• Recent Developments
Key Offerings:
• Past Market Size and Competitive Landscape (2022 to 2029)
• Past Pricing and price curve by region (2022 to 2029)
• Market Size, Share, Size and Forecast by different segment | 2022-2029
• Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
• Market Segmentation - A detailed analysis by growth and trend
• Competitive Landscape - Profiles of selected key players by region from a strategic perspective
• Competitive landscape - Market Leaders, Market Followers, Regional player
• Competitive benchmarking of key players by region
• PESTLE Analysis
• PORTER's analysis
• Value chain and supply chain analysis
• Legal Aspects of business by region
• Lucrative business opportunities with SWOT analysis
• Recommendations
More Related Reports:
Global Antiseptics and Disinfectants Market : https://www.maximizemarketresearch.com/market-report/global-antiseptics-and-disinfectants-market/39163/
Global Electric Shavers Market : https://www.maximizemarketresearch.com/market-report/global-electric-shavers-market/29577/
Global Baby Monitors Market : https://www.maximizemarketresearch.com/market-report/global-baby-monitors-market/71510/
Organic Bedding Market : https://www.maximizemarketresearch.com/market-report/organic-bedding-market/186994/
Global Preparative and Process Chromatography Market: https://www.maximizemarketresearch.com/market-report/global-preparative-and-process-chromatography-market/16874/
Global NGS Sample Preparation Market : https://www.maximizemarketresearch.com/market-report/global-ngs-sample-preparation-market/33020/
Automotive Smart Tire Market : https://www.maximizemarketresearch.com/market-report/global-automotive-smart-tire-market/70519/
Global Levulinic Acid Market : https://www.maximizemarketresearch.com/market-report/global-levulinic-acid-market/25821/
Global Cold Chain Monitoring Market : https://www.maximizemarketresearch.com/market-report/global-cold-chain-monitoring-market/108750/
Global Extruded Plastics Market : https://www.maximizemarketresearch.com/market-report/global-extruded-plastics-market/33035/
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 mailto:sales@maximizemarketresearch.com
🌐 https://www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of the majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema Therapeutic Market to reach USD 14.19 Bn by 2029, emerging at a CAGR of 16.79 percent and forecast 2023-2029 here
News-ID: 3230032 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Power Semiconductor Market to Reach USD 51.83 Billion by 2030 at 3.18% CAGR - Po …
According to a new report by Maximize Market Research, the global power semiconductor market was valued at USD 41.63 billion in 2023 and is projected to reach USD 51.83 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.18% over the forecast period 2024-2030.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/28191/
♦ Key Highlights
Market Size & CAGR: USD 41.63 Bn in 2023, expected to reach USD 51.83 Bn by…
Microneedle Drug Delivery Systems Market Set to Reach US $ 9.46 Billion by 2030 …
According to a new report by Maximize Market Research, the global microneedle drug delivery systems market was valued at roughly US $ 6.11 billion in 2024 and is projected to reach approximately US $ 9.46 billion by 2030, growing at a compound annual growth rate (CAGR) of around 7.7%.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/215694/
♦ Key Highlights
Market size & CAGR: Estimated at ~US $ 6.11 billion in 2024, forecast to…
Automotive Paints Market Forecast to Reach USD 15.77 Billion by 2030 at 4.7 % CA …
According to a new report by Maximize Market Research, the global automotive paints market was valued at USD 10.85 billion in 2023 and is projected to reach USD 15.77 billion by 2030, growing at a CAGR of approximately 4.7 % during 2024-2030. The forecast covers global coatings used in vehicle manufacturing and refinish applications, with a focus on key regions such as Asia-Pacific, North America and Europe.
► Get a sample…
Petrochemicals Market Set to Reach USD 1,122.31 Billion by 2032 at a CAGR of 6.5 …
According to a new report by Maximize Market Research, the global petrochemicals market was valued at USD 678.13 billion in 2024 and is projected to reach USD 1,122.31 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032. The growth is anchored in expanding demand across automotive, electronics, construction, and packaging industries.
► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/126575/
♦ Key Highlights
Market size + CAGR:…
More Releases for Hereditary
Hereditary Angioedema Market: An In-Depth Analysis
In 2024, the market for Hereditary Angioedema Market was valued at USD 3.1 billion. It is anticipated to grow to USD 5.9 billion by 2033, with a CAGR of 6.82% over the period 2026-2033.
Hereditary Angioedema Market Overview
The global hereditary angioedema therapeutics market is experiencing significant expansion, driven by increasing awareness, improved diagnostic capabilities, and the introduction of novel treatment options. Advances in genetic research have enabled early and accurate…
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Hereditary Hemochromatosis Market - Redefining Care, Inspiring Hope: Hereditary …
Newark, New Castle, USA: The "Hereditary Hemochromatosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hereditary Hemochromatosis Market: https://www.growthplusreports.com/report/hereditary-hemochromatosis-market/8793
This latest report researches the industry structure, sales, revenue,…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Global Hereditary Angioedema Market report from Global Insight Services is the single authoritative source of intelligence on hereditary angioedema market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…
